Curaleaf Applauds President Trump’s Significant Cannabis Rescheduling Decision Curaleaf Holdings commends President Trump’s decision to reschedule cannabis, marking a pivotal shift in federal cannabis policy, supporting research and access.

Curaleaf Applauds President Trump’s Significant Cannabis Rescheduling Decision #United_States #Stamford #Trump_administration #Curaleaf #Cannabis_Rescheduling

MediPharm Labs Seizes Unique Opportunities Amid Cannabis Rescheduling Discussions in the US MediPharm Labs is strategically positioned to benefit from the potential rescheduling of cannabis in the United States. Their unique FDA registration sets them apart.

MediPharm Labs Seizes Unique Opportunities Amid Cannabis Rescheduling Discussions in the US #Canada #Toronto #FDA_Registration #MediPharm_Labs #Cannabis_Rescheduling